Sweden· SE-20170418000030
Amsalyo 75 mg Pulver till koncentrat till infusionsvätska, lösning
A medicinal product containing amsacrine, registered in Sweden by Eurocept International B.V..
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Amsacrine
- Manufacturer
- Eurocept International B.V.
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20170418000030
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Amsacrine in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayAmlyoEurocept
- FinlandAmsalyoEurocept International BV
- IrelandAmsalyo 75 mg powder for concentration for solution infusionEurocept International BV
- IcelandAmsalyoEurocept International B.V.
- United KingdomAmsidine 75mg/1.5ml concentrate and solvent for solution for infusion vialsEurocept International bv
- GermanyAmlyoEurocept International Bv
- FranceAMSALYO 75 mg, poudre pour solution pour perfusionEUROCEPT INTERNATIONAL (PAYS-BAS)
- SpainAMEKRIN 75 MG/1,5 ML CONCENTRADO Y DISOLVENTE PARA CONCENTRADO PARA SOLUCION PARA PERFUSIONEurocept International B.V.
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Austria · Amlyo
- Germany · Amlyo, Amsidyl
- Denmark · Amsalyo
- Finland · Amsalyo
- France · Amsalyo
- Croatia · Amlyo
- Ireland · Amsalyo
- Iceland · Amsalyo
- Italy · Amsalyo
- Luxembourg · Amsalyo
- Netherlands · Amsalyo
- Norway · Amsalyo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5dc4862a-41a6-4cb3-9e41-3a978546eca3 GET /v1/drugs/5dc4862a-41a6-4cb3-9e41-3a978546eca3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PAR",
"sPAR",
"PL",
"SmPC"
],
"se_npl_id": "20170418000030",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20170418000030",
"product_doc_link": "https://docetp.mpa.se/LMF/Amsalyo%20powder%20for%20concentrate%20for%20solution%20for%20infusion%20SmPC_09001bee8491f0ce.pdf"
}See everything about amsacrine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.